CEO position of a start-up company to commercialise an implantable medical device (day per week initially)
FaciliFlow is being developed at Imperial College London as an Implantable Device for prevention and treatment of Breast Cancer-Related Lymphoedema (BCRL). The IP is wholly owned by Professor Moore.
They are seeking an individual who wants to make a positive and significant difference to the medical device industry, and who would like to be part of a journey towards offering a solution for this currently incurable condition affecting approximately 20% of breast cancer patients.
The CEO will define and establish modes of engagement and partnership agreements as required and be capable of building a successful, scalable and profitable business. The role requires a background in MedTech business potentially gained as a CEO/Commercial Director of a global medical device company, or maybe in a senior management or business development role within this space and realised value for shareholders. Ideally, the candidate will bring a wealth of knowledge and networks in the initial target markets, which include the USA, China and EU countries.
The role holder will be investor-savvy, with connections to angel networks and leading technology venture capital firms within the US, Europe and China. They should have the ability to raise finance and be accustomed to the demands of an early-stage, resource-constrained business.
The development effort at Imperial College is currently supported by a UK NIHR grant to prepare implants for preclinical and clinical trials. As such, there is only modest remuneration for this role at this stage.
For more information or to apply please reach out to Prof. James E. Moore Jr., Ph.D. firstname.lastname@example.org